237
Participants
Start Date
January 15, 2016
Primary Completion Date
November 21, 2017
Study Completion Date
March 16, 2018
Metformin + Rosuvastatin
Group I: Metformin + Rosuvastatin,
Metformin + placebo
Group II: Metformin + placebo,
placebo + Rosuvastatin
Group III: placebo + Rosuvastatin
Buchoen St. mary's Hospital, Bucheon-si
SeJong Hostpital, Bucheon-si
SoonChunHyang University Bucheon Hospital, Bucheon-si
InJe University Busan paik Hospital, Busan
Inje University Haeundae paik hospital, Busan
Daegu Catholic University Medical Center, Daegu
Youngnam University Hostpital, Daegu
Daeheon Eulji Medical Center, Daejeon
KonYang University Hostpital, Daejeon
Chosun University Hospital, Gwangju
BunDang Jesang Hospital(DMC), Gyeonggi-do
Hallym University Sacred Heart hospital, Gyeonggi-do
HanYang University Guri Hospital, Gyeonggi-do
Inje University Ilsan paik hospital, Gyeonggi-do
Myoung Ji Hospital, Gyeonggi-do
Gachon Gil Hospital, Incheon
Inchoen St. mary's Hospital, Incheon
Eulji Hospital Nowon, Seoul
Hallym University Kangnam Sacred Heart hospital, Seoul
KangBuk SamSung Hospital, Seoul
Kangdong Sacred Heart Hospital, Seoul
KonKuk University Medical Center, Seoul
Korea University Anam Hospital, Seoul
KyungHee University Hospital at Gangdong, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital(Famlily medicine), Seoul
Seoul National University Hospital, Seoul
Severance hospital, Seoul
SoonChunHayng University Hospital Seoul, Seoul
The catholic University of Korea YEOUIDO St mary's Hospital, Seoul
Korea University Guro hospital, Soeul
Ajou University hospital, Suwon
Wonju Severance Christian hospital, Wŏnju
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
INDUSTRY